FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996738870> ?p ?o ?g. }

• W1996738870 endingPage "2530" @default.
• W1996738870 startingPage "2520" @default.
• W1996738870 abstract "The API2-MALT1 fusion oncoprotein is created by the recurrent t(11;18)(q21;q21) chromosomal translocation in mucosa-associated lymphoid tissue (MALT) lymphoma. We identified receptor interacting protein-1 (RIP1) as a novel API2–MALT1-associated protein, and demonstrate that RIP1 is required for API2–MALT1 to stimulate canonical nuclear factor kappa B (NF-κB). API2–MALT1 promotes ubiquitination of RIP1 at lysine (K) 377, which is necessary for full NF-κB activation. Furthermore, we found that TNF receptor-associated factor 2 (TRAF2) recruitment is required for API2–MALT1 to induce RIP1 ubiquitination, NF-κB activation and cellular transformation. Although both TRAF2 and RIP1 interact with the API2 moiety of API2–MALT1, this moiety alone is insufficient to induce RIP1 ubiquitination or activate NF-κB, indicating that API2–MALT1-dependent RIP1 ubiquitination represents a gain of function requiring the concerted actions of both the API2 and MALT1 moieties of the fusion. Intriguingly, constitutive RIP1 ubiquitination was recently demonstrated in several solid tumors, and now our study implicates RIP1 ubiquitination as a critical component of API2–MALT1-dependent lymphomagenesis." @default.
• W1996738870 created "2016-06-24" @default.
• W1996738870 creator A5002852999 @default.
• W1996738870 creator A5008012834 @default.
• W1996738870 creator A5019205026 @default.
• W1996738870 creator A5022169422 @default.
• W1996738870 creator A5026519309 @default.
• W1996738870 creator A5034299577 @default.
• W1996738870 creator A5037139071 @default.
• W1996738870 creator A5055833627 @default.
• W1996738870 creator A5060040445 @default.
• W1996738870 creator A5074314391 @default.
• W1996738870 creator A5091060919 @default.
• W1996738870 date "2013-06-17" @default.
• W1996738870 modified "2023-10-17" @default.
• W1996738870 title "The API2–MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling" @default.
• W1996738870 cites W135294775 @default.
• W1996738870 cites W1520695706 @default.
• W1996738870 cites W1554981631 @default.
• W1996738870 cites W1563487810 @default.
• W1996738870 cites W1694093395 @default.
• W1996738870 cites W1900297117 @default.
• W1996738870 cites W1973680986 @default.
• W1996738870 cites W1980415233 @default.
• W1996738870 cites W1988376074 @default.
• W1996738870 cites W1991860504 @default.
• W1996738870 cites W1996203901 @default.
• W1996738870 cites W1999270640 @default.
• W1996738870 cites W2005572311 @default.
• W1996738870 cites W2006338784 @default.
• W1996738870 cites W2008516360 @default.
• W1996738870 cites W2010479391 @default.
• W1996738870 cites W2012272570 @default.
• W1996738870 cites W2015592267 @default.
• W1996738870 cites W2030262603 @default.
• W1996738870 cites W2032388082 @default.
• W1996738870 cites W2032514624 @default.
• W1996738870 cites W2033562377 @default.
• W1996738870 cites W2036599699 @default.
• W1996738870 cites W2038884068 @default.
• W1996738870 cites W2042421692 @default.
• W1996738870 cites W2045991166 @default.
• W1996738870 cites W2047607345 @default.
• W1996738870 cites W2060945380 @default.
• W1996738870 cites W2063211255 @default.
• W1996738870 cites W2073807266 @default.
• W1996738870 cites W2075083870 @default.
• W1996738870 cites W2080207536 @default.
• W1996738870 cites W2083498707 @default.
• W1996738870 cites W2085637098 @default.
• W1996738870 cites W2089394364 @default.
• W1996738870 cites W2090124817 @default.
• W1996738870 cites W2098549833 @default.
• W1996738870 cites W2105451879 @default.
• W1996738870 cites W2111310880 @default.
• W1996738870 cites W2124249714 @default.
• W1996738870 cites W2125185693 @default.
• W1996738870 cites W2135332272 @default.
• W1996738870 cites W2136084746 @default.
• W1996738870 cites W2137823685 @default.
• W1996738870 cites W2138141169 @default.
• W1996738870 cites W2144064491 @default.
• W1996738870 cites W2151469020 @default.
• W1996738870 cites W2154542711 @default.
• W1996738870 cites W2158662692 @default.
• W1996738870 cites W2159097496 @default.
• W1996738870 cites W2164261107 @default.
• W1996738870 doi "https://doi.org/10.1038/onc.2013.195" @default.
• W1996738870 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4237018" @default.
• W1996738870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23770847" @default.
• W1996738870 hasPublicationYear "2013" @default.
• W1996738870 type Work @default.
• W1996738870 sameAs 1996738870 @default.
• W1996738870 citedByCount "21" @default.
• W1996738870 countsByYear W19967388702014 @default.
• W1996738870 countsByYear W19967388702015 @default.
• W1996738870 countsByYear W19967388702016 @default.
• W1996738870 countsByYear W19967388702017 @default.
• W1996738870 countsByYear W19967388702019 @default.
• W1996738870 countsByYear W19967388702020 @default.
• W1996738870 countsByYear W19967388702021 @default.
• W1996738870 countsByYear W19967388702022 @default.
• W1996738870 countsByYear W19967388702023 @default.
• W1996738870 crossrefType "journal-article" @default.
• W1996738870 hasAuthorship W1996738870A5002852999 @default.
• W1996738870 hasAuthorship W1996738870A5008012834 @default.
• W1996738870 hasAuthorship W1996738870A5019205026 @default.
• W1996738870 hasAuthorship W1996738870A5022169422 @default.
• W1996738870 hasAuthorship W1996738870A5026519309 @default.
• W1996738870 hasAuthorship W1996738870A5034299577 @default.
• W1996738870 hasAuthorship W1996738870A5037139071 @default.
• W1996738870 hasAuthorship W1996738870A5055833627 @default.
• W1996738870 hasAuthorship W1996738870A5060040445 @default.
• W1996738870 hasAuthorship W1996738870A5074314391 @default.
• W1996738870 hasAuthorship W1996738870A5091060919 @default.
• W1996738870 hasBestOaLocation W19967388701 @default.
• W1996738870 hasConcept C104317684 @default.
• W1996738870 hasConcept C123298856 @default.

• next